Commercial CBD Products Caused Neurotoxicity Linked to Heavy Metal Contamination
Two commercial CBD powder products containing lead, chromium, and other heavy metals caused oxidative stress, mitochondrial damage, and reduced viability in human neuronal cells.
Quick Facts
What This Study Found
Treatment with commercial CBD samples at 50 micrograms/mL significantly increased reactive oxygen species, reduced the GSH/GSSG ratio (indicating oxidative stress), elevated lipid peroxidation, inhibited key antioxidant enzymes (CAT, SOD, GPx, GR), and decreased mitochondrial content in neuroblastoma cells.
Key Numbers
Both samples contained ~51% CBD. White sample contaminated with boron, lead, silicon, zinc. Pink sample contaminated with boron, iron, silicon, chromium. At 10 and 50 micrograms/mL, both samples reduced cell viability in a concentration-dependent manner. All four major antioxidant enzymes were significantly inhibited at 50 micrograms/mL.
How They Did This
Two commercially available CBD powder samples were analyzed for cannabinoid content and elemental contamination, then applied to SH-SY5Y neuroblastoma cells at various concentrations for 48 hours. Oxidative stress markers, antioxidant enzyme activity, and mitochondrial function were assessed.
Why This Research Matters
The CBD market has grown faster than regulation can keep pace. This study provides concrete laboratory evidence that contaminated products can damage neurons, underscoring calls for mandatory testing and quality standards.
The Bigger Picture
Previous studies have documented widespread mislabeling and contamination in CBD products, but few have directly measured the biological consequences. This study bridges that gap by showing that real commercial products can cause measurable cellular damage, adding urgency to regulatory discussions.
What This Study Doesn't Tell Us
Only two commercial products tested. Cell culture conditions do not replicate human exposure. Cannot separate CBD effects from heavy metal effects. Neuroblastoma cells may respond differently than normal neurons. Concentrations used may not reflect realistic brain tissue levels.
Questions This Raises
- ?How much of the neurotoxicity was from CBD itself versus the heavy metal contamination
- ?What percentage of commercial CBD products would produce similar results
Trust & Context
- Key Stat:
- Evidence Grade:
- Laboratory study with appropriate controls and multiple outcome measures, but only two products tested and cell culture results have limited human applicability.
- Study Age:
- Published 2025.
- Original Title:
- Oxidative stress and mitochondrial dysfunction in neuronal cells induced by commercial CBD products.
- Published In:
- Chemico-biological interactions, 421, 111785 (2025)
- Authors:
- Sanz-Pérez, A(3), Anaya, B J(2), Fraguas-Sánchez, A I(3), Serrano, D R, Pérez, T, Spineli, M, Basilicata, P, Pieri, M, González-Burgos, E
- Database ID:
- RTHC-07574
Evidence Hierarchy
Frequently Asked Questions
Should I be worried about the CBD products I use?
This study tested only two products and found contamination in both. Third-party tested products with certificates of analysis (COAs) from reputable labs are less likely to have these issues, but the study highlights why independent testing matters.
Was the damage from CBD or from the contaminants?
The study could not fully separate the two. Both products contained similar CBD levels but different metal contaminants and produced similar neurotoxic effects, suggesting that contamination contributed significantly.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
- how-to-tell-if-weed-is-moldy
Cite This Study
https://rethinkthc.com/research/RTHC-07574APA
Sanz-Pérez, A; Anaya, B J; Fraguas-Sánchez, A I; Serrano, D R; Pérez, T; Spineli, M; Basilicata, P; Pieri, M; González-Burgos, E. (2025). Oxidative stress and mitochondrial dysfunction in neuronal cells induced by commercial CBD products.. Chemico-biological interactions, 421, 111785. https://doi.org/10.1016/j.cbi.2025.111785
MLA
Sanz-Pérez, A, et al. "Oxidative stress and mitochondrial dysfunction in neuronal cells induced by commercial CBD products.." Chemico-biological interactions, 2025. https://doi.org/10.1016/j.cbi.2025.111785
RethinkTHC
RethinkTHC Research Database. "Oxidative stress and mitochondrial dysfunction in neuronal c..." RTHC-07574. Retrieved from https://rethinkthc.com/research/sanz-perez-2025-oxidative-stress-and-mitochondrial
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.